Medical Journals

Synthesis, Pharmacology, and Structure-activity Relationships of Novel Imidazolones and Pyrrolones As Modulators of Gabaa Receptors.

Authors:
  • Grunwald Christian
  • Rundfeldt Chris
  • Lankau Hans-Joachim
  • Arnold Thomas
  • Höfgen Norbert
  • Dost Rita
  • Egerland Ute
  • Hofmann Hans-Jörg
  • Unverferth Klaus

From: elbion AG, Meissner Strasse 191, D-01445 Radebeul, Germany, and Institute of Biochemistry, Faculty of Biosciences, Pharmacy and Psychology, University of Leipzig, Brüderstrasse 34, D-04103 Leipzig, Germany. christian.grunwald@elbion.de

Journal of medicinal chemistry

  • Publish Date: Mar 2006
  • ISSN: 0022-2623
  • Volume: 49
  • Issue: 6
  • Pages: 1855-66
  • Medium: Print
  • Language: English
  • Citation (JAMA): Grunwald Christian, Rundfeldt Chris, Lankau Hans-Joachim, et al. Synthesis, Pharmacology, and Structure-activity Relationships of Novel Imidazolones and Pyrrolones As Modulators of Gabaa Receptors.. J. Med. Chem. Mar 2006;49:1855-66

Abstract

New series of imidazolones and pyrrolones were synthesized. The compounds were tested regarding their anxiolytic properties due to modulation of the GABAA receptor response. Several derivatives exhibit considerable pharmacological activity while lacking the typical side effects of benzodiazepine receptor agonists. 1-(4-chlorophenyl)-4-morpholin-1-yl-1,5-dihydro-imidazol-2-one (2) and 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-one (3) were protective in the pentylenetetrazole test in rats with oral ED50 of 27.4 and 12.8 mg/kg and TD50 (rotarod) of >500 and 265 mg/kg, respectively. The minimum effective dose in the Vogel conflict test was 3 mg/kg for both compounds. Common structure-activity relationship and comparative molecular field analysis models of the various series of derivatives could be established which are in accordance with a GABAA mediated pharmacological action. The findings fit well into an established pharmacophore model. This model is refined by an additional steric restriction feature.

Mesh Headings (Keywords): Administration, Oral, Animals, Anti-Anxiety Agents, Anticonvulsants, Binding Sites, Brain, GABA Antagonists, Imidazoles, Male, Mice, Models, Molecular, Morpholines, Pentylenetetrazole, Piperidines, Pyrroles, Quantitative Structure-Activity Relationship, Radioligand Assay, Rats, Rats, Wistar, Receptors, GABA-A, Rotarod Performance Test, Seizures


Check for Full Text / PubMed Unique Identifier (PMID): 16539371


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.